Table 1 Baseline characteristics.
NLR < 2.74 (N = 825) | NLR ≥ 2.74 (N = 272) | Total (N = 1,097) | p-value | |
|---|---|---|---|---|
Age (median, range) | 48 (20–84) | 45 (22–76) | 47 (20–84) | < 0.001 |
Histologic type | 0.407 | |||
IDC | 771 (93.5%) | 258 (94.9%) | 1,029 (93.8%) | |
Others | 54 (6.5%) | 14 (5.1%) | 68 (6.2%) | |
ER | 0.067 | |||
Positive | 483 (58.5%) | 142 (52.2%) | 625 (57.0%) | |
Negative | 342 (41.5%) | 130 (47.8%) | 472 (43.0%) | |
PR | 0.752 | |||
Positive | 370 (44.8%) | 119 (43.8%) | 489 (44.6%) | |
Negative | 455 (55.2%) | 149 (56.3%) | 608 (55.4%) | |
Subgroup | 0.113 | |||
HR+HER2− | 491 (59.5%) | 147 (54.0%) | 638 (58.2%) | |
TNBC | 334 (40.5%) | 125 (46.0%) | 459 (41.8%) | |
Ki-67* | 0.010 | |||
< 14 | 143 (34.7%) | 34 (23.1%) | 177 (31.7%) | |
≥ 14 | 269 (65.3%) | 113 (76.9%) | 382 (68.3%) | |
cT | 0.025 | |||
1 | 125 (15.2%) | 28 (10.3%) | 153 (13.9%) | |
2 | 558 (67.6%) | 181 (66.5%) | 739 (67.4%) | |
3 | 142 (17.2%) | 63 (23.2%) | 205 (18.7%) | |
cN | 0.444 | |||
Negative | 128 (15.5%) | 37 (13.6%) | 165 (15.0%) | |
Positive | 697 (84.5%) | 235 (86.4%) | 932 (85.0%) | |
pCR | 0.033 | |||
No | 635 (77.0%) | 226 (83.1%) | 861 (78.5%) | |
Yes | 190 (23.0%) | 46 (16.9%) | 236 (21.5%) | |
Regimen | 0.009 | |||
AC-T | 661 (80.1%) | 196 (72.1%) | 857 (78.1%) | |
AC | 26 (3.2%) | 10 (3.7%) | 36 (3.3%) | |
AT | 113 (13.7%) | 47 (17.3%) | 160 (14.6%) | |
Others† | 25 (3.0%) | 19 (7.0%) | 44 (4.0%) |
